Our Mission - to identify asymptomatic, diagnosed Americans with liver fibrosis or early cirrhosis caused by fatty liver disease, and to educate them on the lifestyle changes needed to halt or minimize disease progression.
The following is a broader discussion of the problem
Our goal is to save the lives of people who have no symptoms but are unknowingly destroying their livers. We aim to provide them with information that can help them change their lifestyle before they become ill. It is the mission, duty and purpose of the Fatty Liver Foundation to address, educate, coordinate, and support victims of the growing epidemic of fatty liver disease.
Secondarily we offer information and support to those who have become ill as they cope with end stage liver disease though our goal is to help people not reach that point. Consider the death rate chart below.
Fatty liver disease. NAFLD, affects more than 100 million people in the U.S. The disease stage of fatty liver begins with non-alcoholic fatty liver disease, NAFLD, can progress to non-alcoholic steatohepatitis, NASH, and end stage liver disease called cirrhosis, commonly without symptoms. Obesity is the key driver of this disease process. The most graphic proof that we face a catastrophe is the standard death rate from major disease processes. Note in the chart above that medicine is winning against nearly all medical challenges but liver disease is becoming the angel of death for the 21st century.
In the past 20 years the incidence of NAFLD has increased over 20 times as a result of changes in the American diet and lifestyle and the resulting obesity of the average citizen. The result is that there is a large wave of liver disease moving toward the medical community. A complication is that the damage is usually silent until it becomes life threatening. The average overweight person thinks of being overweight as mostly an appearance issue and not as a very slow but dangerous problem. Obesity induced liver failure is projected to become the number one reason for a liver transplant by 2020.
It is our duty to assist others when we are capable, to provide information to those at risk, and support for ordinary people as they live with silent or apparent liver disease. Our goal is to be very focused on the issue of fat in the liver, why it matters, what it causes, and how to deal with it. For people with active disease we will provide information and support about this very specific kind of liver disease, and the NAFLD/NASH disease process.